22 results
Thumbnail

D1.264 - Assessment by general practitioners of a therapeutic patient education guide for allergic patients

Thumbnail

D1.262 - Clinical significance of a basophil activation test for Japanese beekeepers naturally sensitized to honey bee venom

Thumbnail

D1.265 - Component-Resolved Diagnosis and Clinical Profiles of Anisakis Allergy in Japan

Thumbnail

D1.266 - Investigation of anaphylaxis in mastocytosis mouse models

Thumbnail

D1.267 - Recurrence of perioperative anaphylaxis: analysis of a multicenter cohort

Thumbnail

D1.268 - The endothelial glycocalyx as a therapeutic target in anaphylaxis

Thumbnail

D1.269 - Deciphering cardiovascular profiles in sera and extracellular vesicles from anaphylactic patients. Impact in endothelial cells

Thumbnail

D1.270 - Anaphylaxis and Adrenaline: Knowledge gaps with critical consequences

Thumbnail

D1.271 - Bovine gelatine-induced anaphylaxis brought on by eating beef, sweets containing gelatin, and medications

Thumbnail

D1.272 - Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom

Thumbnail

D1.273 - Anaphylactic Reaction Following Sulphur Hexafluoride Administration

Thumbnail

D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Thumbnail

D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old

Thumbnail

D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy